Line 50: | Line 50: | ||
− | <u><p class="title1" id="select1"> | + | <u><p class="title1" id="select1">Backbone</p></u> |
<p class="texteb"> | <p class="texteb"> | ||
The use of replicative plasmid in <i>Bacillus subtilis</i> is not as usual as in <i>E. coli</i>. | The use of replicative plasmid in <i>Bacillus subtilis</i> is not as usual as in <i>E. coli</i>. | ||
− | Only one of such plasmid is described in the iGEM registry (<a href="http://parts.igem.org/Part:BBa_K823026"> | + | Only one of such plasmid is described in the iGEM registry (<a href="http://parts.igem.org/Part:BBa_K823026">pSB0K-P</a> from iGEM Munich 2012; |
<a href="http://parts.igem.org/Part:BBa_K823026">BBa_K823026</a> and its slightly modified form <a href="http://parts.igem.org/Part:BBa_K1351040">BBa_K1351040</a>). | <a href="http://parts.igem.org/Part:BBa_K823026">BBa_K823026</a> and its slightly modified form <a href="http://parts.igem.org/Part:BBa_K1351040">BBa_K1351040</a>). | ||
Since none of them were available from the registry, we eventually got <a href="http://parts.igem.org/Part:BBa_K1351040">BBa_K1351040</a> from ex-Munich iGEMers (thanks guys!). | Since none of them were available from the registry, we eventually got <a href="http://parts.igem.org/Part:BBa_K1351040">BBa_K1351040</a> from ex-Munich iGEMers (thanks guys!). | ||
Line 65: | Line 65: | ||
− | <u><p class="title1" id="select1"> | + | <u><p class="title1" id="select1">pSB0K-Mini: new part <a href="http://parts.igem.org/Part:BBa_K1937001">BBa_K1937001</a></p></u> |
<p class="texteb"> | <p class="texteb"> | ||
− | We reasoned that most of the | + | We reasoned that most of the pSB0K-P plasmid content were of no need to our project (LacY, RFP, |
− | LacI…). Since supressing these elements also suppressed the | + | LacI…). Since supressing these elements also suppressed the suffix and prefix, primers with new suffix |
and prefix were designed to amplify the needed regions (selection markers and replication origins; | and prefix were designed to amplify the needed regions (selection markers and replication origins; | ||
Line 80: | Line 80: | ||
<center><img src="https://static.igem.org/mediawiki/2016/e/e7/Toulouse_France_backbone1.jpg" style="width:40%; margin:20px 20px;"></center> | <center><img src="https://static.igem.org/mediawiki/2016/e/e7/Toulouse_France_backbone1.jpg" style="width:40%; margin:20px 20px;"></center> | ||
<b style="font-size:12px;"> | <b style="font-size:12px;"> | ||
− | Figure 1: reduction of the | + | Figure 1: reduction of the pSB0K-P plasmid. Position of the primers are indicated by the blue arrow on pSB0K-P (left part of the figure). The resulting PCR fragment is the blue pointed line. After digestion by NheI and self-ligation, the resulting pSB0K-Mini plasmid was obtained (right part of the figure). |
</b> | </b> | ||
<br><br> | <br><br> | ||
Line 100: | Line 100: | ||
<p class="texteb"> | <p class="texteb"> | ||
− | With the success of the | + | With the success of the pSB0K-Mini, we decided that we should try to go even further by isolating |
what is the very essence of this replicative <i>Bacillus</i> plasmid: its <i>Bacillus</i> repU origin and its kanamycin | what is the very essence of this replicative <i>Bacillus</i> plasmid: its <i>Bacillus</i> repU origin and its kanamycin | ||
Line 111: | Line 111: | ||
<center><img src="https://static.igem.org/mediawiki/2016/c/ca/Toulouse_France_backbone2.jpg" style="width:40%; margin:20px 20px;"></center> | <center><img src="https://static.igem.org/mediawiki/2016/c/ca/Toulouse_France_backbone2.jpg" style="width:40%; margin:20px 20px;"></center> | ||
<b style="font-size:12px;"> | <b style="font-size:12px;"> | ||
− | Figure 2: creation of the OriKan cassette. Position of the primers are indicated by the blue arrow on | + | Figure 2: creation of the OriKan cassette. Position of the primers are indicated by the blue arrow on pSB0K-P (left part of the figure). The resulting PCR fragment is the blue pointed line. After digestion by EcoRI and PstI and ligation in the pSB1C3 plasmid, the resulting pSB1C3-OriKan plasmid was obtained (right part of the figure). |
</b> | </b> | ||
<br><br> | <br><br> | ||
Line 125: | Line 125: | ||
<center><img src="https://static.igem.org/mediawiki/2016/1/18/Toulouse_France_backbone3.jpg" style="width:30%; margin:20px 20px;"></center> | <center><img src="https://static.igem.org/mediawiki/2016/1/18/Toulouse_France_backbone3.jpg" style="width:30%; margin:20px 20px;"></center> | ||
<b style="font-size:12px;"> | <b style="font-size:12px;"> | ||
− | Figure 3: validation of the pSB1C3-Orikan presence in <i>B. subtilis</i>. PCR on colonies was performed using primers hybridizing in the kanamycine resistance gene and in the suffix. The colonies were issued from the transformation of <i>B. subtilis</i> by pSB1C3-Orikan (assays), by the | + | Figure 3: validation of the pSB1C3-Orikan presence in <i>B. subtilis</i>. PCR on colonies was performed using primers hybridizing in the kanamycine resistance gene and in the suffix. The colonies were issued from the transformation of <i>B. subtilis</i> by pSB1C3-Orikan (assays), by the pSB0K-P plasmid (negative control), or from the transformation of <i>E. coli</i> by pSB1C3-Orikan (positive control). |
</b> | </b> | ||
Line 142: | Line 142: | ||
<i>Bacillus subtilis</i> in the registry. Even managing to obtained one was not the end of our quest since it | <i>Bacillus subtilis</i> in the registry. Even managing to obtained one was not the end of our quest since it | ||
− | + | appears to be too big for further sub-cloning purposes. In this context, obtaining the pSB0K-Mini | |
has been a great step forward for us as it allowed a fast progression of our project cloning steps. | has been a great step forward for us as it allowed a fast progression of our project cloning steps. | ||
Line 161: | Line 161: | ||
<div class="column full_size"> | <div class="column full_size"> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<center> | <center> | ||
<a class="button-home" href="https://2016.igem.org/Team:Toulouse_France/Design" style="border: 1px solid #282828;-webkit-border-radius: 5px;-moz-border-radius: 5px;border-radius: 5px; | <a class="button-home" href="https://2016.igem.org/Team:Toulouse_France/Design" style="border: 1px solid #282828;-webkit-border-radius: 5px;-moz-border-radius: 5px;border-radius: 5px; | ||
− | padding: 15px 15px; color: black; text-decoration: none; font-size: 18px; background: none; display: block; width: 250px; background-color:#7FFFD4">Design of our project</a | + | padding: 15px 15px; color: black; text-decoration: none; font-size: 18px; background: none; display: block; width: 250px; background-color:#7FFFD4">BACK: Design of our project</a> |
− | + | ||
− | + | <br><br> | |
− | + | ||
− | + | ||
<a class="button-home" href="https://2016.igem.org/Team:Toulouse_France/Experiments" style="border: 1px solid #282828;-webkit-border-radius: 5px;-moz-border-radius: 5px;border-radius: 5px; | <a class="button-home" href="https://2016.igem.org/Team:Toulouse_France/Experiments" style="border: 1px solid #282828;-webkit-border-radius: 5px;-moz-border-radius: 5px;border-radius: 5px; | ||
− | padding: 15px 15px; color: black; text-decoration: none; font-size: 18px; background: none; display: block; width: 250px; background-color:#F4A460">Our results | + | padding: 15px 15px; color: black; text-decoration: none; font-size: 18px; background: none; display: block; width: 250px; background-color:#F4A460">NEXT: Our results</a> |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</center> | </center> | ||
Revision as of 17:58, 19 October 2016
Backbones description
Backbone
The use of replicative plasmid in Bacillus subtilis is not as usual as in E. coli.
Only one of such plasmid is described in the iGEM registry (pSB0K-P from iGEM Munich 2012;
BBa_K823026 and its slightly modified form BBa_K1351040).
Since none of them were available from the registry, we eventually got BBa_K1351040 from ex-Munich iGEMers (thanks guys!).
However, this plasmid is already huge (9358 bp), and we needed to insert great fragments inside.
Our first attempts to clone in BBa_K1351040 failed. We therefore decided to operate a reduction of the plasmid size.
pSB0K-Mini: new part BBa_K1937001
We reasoned that most of the pSB0K-P plasmid content were of no need to our project (LacY, RFP, LacI…). Since supressing these elements also suppressed the suffix and prefix, primers with new suffix and prefix were designed to amplify the needed regions (selection markers and replication origins; figure 1). Nhe1 restriction site was also added at the 5’ end of each primers to circularize the PCR product.
The new plasmid size is smaller by 3604 bp. It was purified from E. coli and used to successfully transform B. subtilis. Integrity of the whole sequence was assessed by sequencing using 10 primers distributed all along the sequence. This new plasmid was then used to create most of the Bacillus subtilis parts of our project, demonstrating its efficiency as a new backbone for Bacillus based projects.
OriKan (new part BBa_K1937002): and they all became Bacillus plasmids…
With the success of the pSB0K-Mini, we decided that we should try to go even further by isolating what is the very essence of this replicative Bacillus plasmid: its Bacillus repU origin and its kanamycin resistance gene. We amplified the region containing these two elements with primers carrying the iGEM suffix and prefix (figure 2).
The fragment was then sub-cloned in the pSB1C3 plasmid (between the EcoRI/PstI restriction sites). We checked the capacity of this new pSB1C3-Orikan plasmid to maintain in Bacillus subtilis and we were delighted to obtain clones. The actual presence of pSB1C3-Orikan in this colonies was assessed by PCR (figure 3). The sequence integrity of the OriKan cassette was also verified.
These results demonstrate that the OriKan biobrick is sufficient to turn any pSB1C3 plasmid into a Bacillus subtilis compatible replicative plasmid.
Conclusions and perspectives
The start of our project has been complicated by the absence of available replicative plasmid for
Bacillus subtilis in the registry. Even managing to obtained one was not the end of our quest since it
appears to be too big for further sub-cloning purposes. In this context, obtaining the pSB0K-Mini
has been a great step forward for us as it allowed a fast progression of our project cloning steps.
Moreover, we are also very proud of the OriKan biobrick. There was no such part in the registry. Its
capacity to simply functionalize any registry part for Bacillus subtilis (and likely some other gram
positive strains) is invaluable for the ever growing numbers of iGEM projects based on these
organisms. We therefore applied for the OriKan biobrick to be selected as “best composite part”.
Website by Team iGEM Toulouse 2016